Menu
MSE PRO tert-Butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate, ≥97.0% Purity - MSE Supplies LLC

MSE PRO tert-Butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate, ≥97.0% Purity

SKU: CM1387

  • $ 42995
  • Save $ 5190


MSE PRO™ tert-Butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate, ≥97.0% Purity

MSE PRO™ tert-Butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate is a highly valuable and versatile building block with significant potential in the pharmaceutical and fine chemicals industries. The unique structural features of this molecule make it an attractive target for a wide range of synthetic applications. The tert-butyl carboxylate group on this molecule provides a valuable handle for further synthetic transformations. This functional group can be used for protection, activation, or incorporation into more complex molecular scaffolds, expanding the utility of this building block.

MSE Supplies offers various N-heterocyclic drug small molecules and other chemical reagents. Please contact us for bulk orders.

Technical Specifications:

CAS No. 1246551-25-6
Chemical name tert-Butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate
Synonym(s)
  • tert-butyl 3-oxo-1,2,5,6,8,8a-hexahydroimidazo[5,1-c]pyrazine-7-carboxylate
  • tert-butyl-hexahydro-3-oxoimidazo[1,5-a]pyrazine-7(1H)-carboxylate
Molecular formula C11H19N3O3 
Pack size

1 g (CM1387)

Molecular weight 241.29 g/mol
Purity ≥97.0% (NMR) 
Boiling point 426.6±44.0 °C (Predicted)
Melting point  212-213 °C
Density   1.23±0.1 g/cm3 (Predicted)
pKa 14.25±0.20 (Predicted)
Appearance Colorless to light yellow (Viscous liquid)
Storage  2-8 °C, protect from light


References:

[1] Zhu, Y., Xia, S., Zhu, M., Yi, W., Cheng, J., Song, G., ... & Lu, P. (2010). Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors. European journal of medicinal chemistry45(11), 4953-4962.

[2] Dehnavi, F., Alizadeh, S. R., & Ebrahimzadeh, M. A. (2021). Pyrrolopyrazine derivatives: Synthetic approaches and biological activities. Medicinal Chemistry Research, 1-26.